Sciact
  • EN
  • RU

On the Origin of Better Hemocompatibility of the BCxNyOz Coatings Full article

Journal Applied Surface Science
ISSN: 0169-4332
Output data Year: 2022, Volume: 576, Article number : 151760, Pages count : 14 DOI: 10.1016/j.apsusc.2021.151760
Tags BCxNyOz; Bioactive coatings; Hemocompatibility; Metallic implant; Ti-6Al-4V
Authors Bhaskar Nitu 1 , Sulyaeva Veronica 2 , Gatapova Elizaveta 3 , Kaichev Vasily 4 , Khomyakov Maxim 5 , Kolodin Alexey 2 , Kosinova Marina 2 , Basu Bikramjit 1
Affiliations
1 Materials Research Center, Indian Institute of Science, Bangalore, Karnataka 560012, India
2 Nikolaev Institute of Inorganic Chemistry SB RAS, 3, Acad. Lavrentiev Ave., Novosibirsk 630090, Russia
3 Kutateladze Institute of Thermophysics SB RAS, 1, Acad. Lavrentiev Ave., Novosibirsk 630090, Russia
4 Boreskov Institute of Catalysis SB RAS, 5, Acad. Lavrentiev Ave., Novosibirsk 630090, Russia
5 Institute of Laser Physics SB RAS, 15B, Acad. Lavrentiev Ave., Novosibirsk 630090, Russia

Funding (2)

1 Department of Science and Technology SR/WOS-A/LS-513/2017
2 Russian Foundation for Basic Research
Department of Science and Technology
18-53-80016 (АААА-А18-118091290003-8) / DST/IMRCD/BRICS/PilotCall2/SCBCPCVD/2018

Abstract: The development of hemocompatible coatings on metallic implants is one of the challenges for blood-contacting implantable devices. In this paper, we investigated the blood-material interaction of BCxNyOz coatings deposited on Ti-6Al-4V substrates, using reactive radiofrequency magnetron sputtering technique with variation in nitrogen (N2) flow rate. A series of experiments, including hemolysis tests, erythrocytes, and platelets adhesion and activation analysis, dynamic blood coagulation, and plasma recalcification time tests, were performed to understand the blood-material interactions, qualitatively and quantitatively. The results revealed that the degree of hemolysis on all the samples was below 2.5%, suggesting their favourable interaction with RBCs. The interactions between erythrocytes and platelets with all the BCxNyOz coatings were reduced significantly compared to Ti-6Al-4V. BCxNyOz coatings could substantially delay the time of blood coagulation to the period of 60 min. The plasma recalcification time of coatings was also increased significantly. An effort has been made to rationalize the difference in hardness or blood compatibility parameters in terms of [N]/[B] or [N]/[C] ratio. The present study conclusively establishes that BCxNyOz coatings can significantly enhance hemocompatibility, thereby opening up a myriad of biomedical applications. © 2021
Cite: Bhaskar N. , Sulyaeva V. , Gatapova E. , Kaichev V. , Khomyakov M. , Kolodin A. , Kosinova M. , Basu B.
On the Origin of Better Hemocompatibility of the BCxNyOz Coatings
Applied Surface Science. 2022. V.576. 151760 :1-14. DOI: 10.1016/j.apsusc.2021.151760 WOS Scopus РИНЦ AN OpenAlex
Dates:
Submitted: Jul 16, 2021
Accepted: Oct 27, 2021
Published online: Oct 31, 2021
Published print: Feb 1, 2022
Identifiers:
Web of science: WOS:000729414000004
Scopus: 2-s2.0-85118859142
Elibrary: 47524568
Chemical Abstracts: 2021:2511931
OpenAlex: W3210777082
Citing:
DB Citing
Scopus 9
Web of science 8
Elibrary 5
OpenAlex 12
Altmetrics: